Lyric Pharmaceuticals is a developer of gastrointestinal therapeutics and drug products... Read more
Lyric Pharmaceuticals is a developer of gastrointestinal therapeutics and drug products... Read more
News
Mar 05, 2018
PR Newswire
Press Release: Lyricpharma : Lyric Completes Enrollment in Phase 2 PROMOTE Study of LP101 (Ulimorelin) in Enteral Feeding Intolerance
Jan 23, 2018
ForImmediateRelease
Press Release: Lyricpharma : Lyric Pharmaceuticals Presents Data at ASPEN Conference on the Incidence of Enteral Feeding Intolerance in the ICU
Jan 17, 2018
ForImmediateRelease
Press Release: Lyricpharma : Lyric Pharma Granted FDA Fast Track Designation for Lead Product Ulimorelin for Enteral Feeding Intolerance (EFI)
Mar 02, 2015
SILICONTAP
Lyricpharma: Lyric Pharmaceuticals Gets $20.4M For GI Disease Research
Feb 27, 2015
BIOCENTURY
Lyricpharma: Lyric debuts with $20.4M series A
Feb 27, 2015
DRUG DISCOVERY & DEVELOPMENT
Lyricpharma: Lyric Pharmaceuticals: $20.4M Series A Funding Round
Feb 26, 2015
FIERCE BIOTECH
Lyricpharma: Stealthy Lyric Pharma bags $20M for its gastro drug
Feb 26, 2015
FINSMEs
Lyricpharma: Lyric Pharmaceuticals Holds Initial Closing of $20.4M Series A Financing
Feb 26, 2015
PR NEWSWIRE
Press Release: Lyricpharma : Lyric Pharmaceuticals Announces $20.4M Series A Funding Round
Feb 26, 2015
ST. LOUIS BUSINESS JOURNAL
Lyricpharma: RiverVest invests in pharma startup's $20.4 million funding
Lyricpharma Competitors
1
2
3
4
5
6
7
8
9
10